undamentalytics Newsletter
Sign in

Hims & Hers Health, Inc. income statement

In fiscal 2025, Hims & Hers Health, Inc. reported revenue of $2.35bn, up 59.0% on the year before, operating income of $106m (a 4.5% margin) and net income of $128m, or $0.51 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue831492725278721,4772,3482,578
Cost of revenue383967118157303614814
Gross profit451092044097151,1731,7331,764
Selling, general and administrative5666184—————
General and administrative———98130168273432
Operating income−74−15−115−69−2962106−155
Interest expense000—————
Income before tax−72−18−111−66−2272124−164
Income tax00−3−02−54−4−22
Net income−72−18−108−66−24126128−142
Diluted EPS−$0.41−$0.10−$0.58−$0.32−$0.11$0.53$0.51−$0.57
Diluted shares (average)174m177m187m205m209m237m258m247m
EBITDA−74−14−111−61−2079160−67

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: AVAH vs HIMSCHE vs HIMSHIMS vs PRVAHIMS vs RDNT

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Hims & Hers Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Hims & Hers Health, Inc.